| CAS NO: | 21343-40-8 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | Ercalcidiol is a metabolite ofvitamin D2, is regarded as an indicator of vitamin D nutritional status. | ||||||||||||||||
| IC50& Target |
| ||||||||||||||||
| 体外研究 (In Vitro) | Differentiation between Ercalcidiol (25(OH)D2) and 25(OH)D3is important for monitoring vitamin D therapy, as vitamin D2is the predominant prescription form. The half-life of Ercalcidiol is shorter than that of 25(OH)D3and it binds less well to the vitamin D binding protein, making it less potent and, therefore, required to be administered at much higher doses than vitamin D3. Some currently used assays have a diminished capacity to detect Ercalcidiol, which can lead to dangerous overdosing when attempting to monitor therapy with vitamin D2[2]. | ||||||||||||||||
| 分子量 | 412.65 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C28H44O2 | ||||||||||||||||
| CAS 号 | 21343-40-8 | ||||||||||||||||
| 中文名称 | 25-羟麦角甾醇;25-羟基维生素;25-羟基麦角甾醇;25-羟基维他命 D2;25-羟基维生素 D2 | ||||||||||||||||
| 结构分类 |
| ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 | -20°C, protect from light, stored under nitrogen *该产品在溶液状态不稳定,建议您现用现配,即刻使用。 | ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : ≥ 100 mg/mL(242.34 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现用现配,即刻使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
